Jevantique Lo (HRT)

Ethinyl estradiol is a type of estrogen. Estrogen is a female sex hormone that is important for many functions in the body.

Norethindrone is a type of progesterone. Progesterone is a female hormone that helps regulate ovulation and menstruation.

Jevantique Lo (HRT) is a combination medicine used to relieve symptoms of menopause, including hot flashes and vaginal dryness, burning, and irritation. It is also used to help prevent osteoporosis.

Jevantique Lo may also be used for reasons not mentioned in this medication guide.

Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.

Try to take this medicine at the same time each day.

Jevantique Lo may increase your risk of developing a condition that can lead to uterine cancer. To help lower this risk, your doctor may also want you to take a progestin. Report any unusual vaginal bleeding right away.

Your doctor should check your progress on a regular basis (every 3 to 6 months) to determine whether you should continue this treatment. Self-examine your breasts for lumps on a monthly basis, and have regular mammograms.

If you need major surgery or will be on long-term bed rest, you may need to stop using this medicine for a short time. Any doctor or surgeon who treats you should know that you are using Jevantique Lo.

Store at room temperature away from moisture and heat.

You should not use this medicine if you have: undiagnosed vaginal bleeding, liver disease, a bleeding disorder, if you will have major surgery, or if you have ever had a heart attack, a stroke, a blood clot, or cancer of the breast, uterus/cervix, or vagina.

Do not use if you are pregnant.

This medicine may increase your risk of developing a condition that may lead to uterine cancer. Report any unusual vaginal bleeding right away.

Using this medicine can increase your risk of blood clots, stroke, heart attack, or cancer of the breast, uterus, or ovaries. Jevantique Lo should not be used to prevent heart disease, stroke, or dementia.

You should not use Jevantique Lo if you are allergic to ethinyl estradiol or norethindrone, or if you have:

• unusual vaginal bleeding that has not been checked by a doctor;
• liver disease;
• a bleeding disorder;
• a history of heart attack, stroke, or blood clot; or
• a history of hormone-related cancer, or cancer of the breast, uterus/cervix, or vagina.

Do not use if you are pregnant. Tell your doctor right away if you become pregnant during treatment.

Using this medicine can increase your risk of blood clots, stroke, or heart attack. You are even more at risk if you have high blood pressure, diabetes, high cholesterol, if you are overweight, or if you smoke.

Jevantique Lo should not be used to prevent heart disease, stroke, or dementia, because this medicine may actually increase your risk of developing these conditions.

Tell your doctor if you have ever had:

• heart disease;
• liver problems, or jaundice caused by pregnancy or taking hormones;
• kidney disease;
• hereditary angioedema (an immune system disorder);
• bone cancer;
• lupus;
• asthma;
• epilepsy or other seizure disorder;
• migraines;
• porphyria (a genetic enzyme disorder that causes symptoms affecting the skin or nervous system);
• gallbladder disease;
• endometriosis or uterine fibroid tumors;
• a thyroid disorder; or
• high or low levels of calcium in your blood.

Using Jevantique Lo may increase your risk of cancer of the breast, uterus, or ovaries. Talk with your doctor about this risk.

This medicine can slow breast milk production. Tell your doctor if you are breast-feeding.

Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Jevantique Lo may cause serious side effects. Stop using Jevantique Lo and call your doctor right away if you have:

• heart attack symptoms--chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating;
• increased blood pressure--severe headache, blurred vision, pounding in your neck or ears, anxiety, nosebleed;
• signs of a stroke--sudden numbness or weakness (especially on one side of the body), sudden severe headache, slurred speech, problems with vision or balance;
• signs of a blood clot--sudden vision loss, stabbing chest pain, feeling short of breath, coughing up blood, pain or warmth in one or both legs;
• swelling or tenderness in your stomach;
• jaundice (yellowing of the skin or eyes);
• unusual vaginal bleeding, pelvic pain;
• a breast lump;
• memory problems, confusion, unusual behavior; or
• high levels of calcium in your blood--nausea, vomiting, constipation, increased thirst or urination, muscle weakness, bone pain, lack of energy.

Common side effects of Jevantique Lo may include:

• stomach pain;
• bloating, swelling, weight gain;
• breast pain;
• light vaginal bleeding or spotting;
• thinning scalp hair; or
• headache.

This is not a complete list of side effects, and others may occur. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Take the medicine as soon as you remember, but skip the missed dose if it is nearly time for your next dose. Do not take two doses at once.

Seek emergency medical help or call the Poison Help line at 1-800-222-1222. Signs of an overdose may include nausea, vomiting, or vaginal bleeding.

Do not smoke. It can significantly raise your risk of blood clots, stroke, or heart attack while using Jevantique Lo.

Grapefruit may affect how Jevantique Lo works and cause unwanted side effects. Avoid using grapefruit products.

Sometimes it is not safe to use certain medications together. Some drugs can change the amount of other drugs in your blood, which may increase side effects or make the medications not work as well.

Other drugs may affect Jevantique Lo, including prescription and over-the-counter medicines, vitamins, and Herbal products. Inform your doctor about all the medicines you are currently taking and any new medicine you start or stop using.